Company News in the Life Science Industry

»

Reset 

Hansa Biopharma Interim Report January-June 2019

MALMÖ, Sweden, July 18, 2019 /PRNewswire/ -- Imlifidase benefits highlighted in recent ATC presentations. Expansion outside transplantation with initiation of study in Guillain-Barré Syndrome (GBS) continues.

Read more ››
By: PR Newswire Association LLC. - 18 Jul 2019
Related companies:  Hansa Biopharma AB

Sosei Heptares to Receive US$2.5 Million Milestone Payment from Formosa Pharmaceuticals

- Payment follows IND approval from US FDA for first-in-human clinical trial of APP13007 for post-operative inflammation of the eye

Read more ››
By: PR Newswire Association LLC. - 18 Jul 2019

Outlook on the World Cardiac Monitoring Market to 2024 - ECG Monitor Projected to Dominate

DUBLIN, July 18, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 18 Jul 2019

PhRMA Member Companies Invested Nearly $80 Billion in R&D Last Year

WASHINGTON, July 18, 2019 /PRNewswire/ -- Last year, PhRMA member companies invested a record-setting $79.6 billion in research and development (R&D) according to the Read more ››

By: PR Newswire Association LLC. - 18 Jul 2019
Related companies:  Pharmaceutical Research and Manufacturers of America (PhRMA)

Empiric Health Appoints New VP of Marketing

SALT LAKE CITY, July 18, 2019 /PRNewswire/ -- Empiric Health, a tech-enabled service company with leading edge solutions used to identify unwarranted clinical variation announced that Alycia Parker has joined as Vice President of Marketing. In her role, Alycia will be responsible for marketing... Read more ››

By: PR Newswire Association LLC. - 18 Jul 2019
Related companies:  Empiric Health

Ben-Gurion University Introduces Superior Forensic Blood Detection Test Using Luminescence-Based Detection

BEER-SHEVA, Israel, July 18, 2019 /PRNewswire/ -- BGN Technologies, the technology transfer company of Ben-Gurion University of the Negev (BGU), introduces a new chip device that offers superior identification of miniscule... Read more ››

By: PR Newswire Association LLC. - 18 Jul 2019

Quest Diagnostics Welcomes New Members to the Global Diagnostics Network (GDN)

SECAUCUS, N.J., July 18, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the expansion of the Global Diagnostics Network (GDN), a strategic working group of major diagnostic laboratories collaborating to generate... Read more ››

By: PR Newswire Association LLC. - 18 Jul 2019
Related companies:  Quest Diagnostics, Inc.

Liquid Biopsy Performance Comparison of Sysmex Inostics OncoBEAM RAS CRC and BioCartis Idylla ctKRAS Testing Published in Scientific Reports (Nature Journal)

HAMBURG, Germany, July 18, 2019 /PRNewswire/ -- Sysmex Inostics, a global leader in blood based circulating tumor DNA (ctDNA) analysis and molecular diagnostics for oncology, today announces publication of a study comparing the performance of plasma RAS mutation detection by two commercial liquid... Read more ››

By: PR Newswire Association LLC. - 18 Jul 2019
Related companies:  Sysmex Inostics Inc.

Genmab Prices its Initial Public Offering of American Depositary Shares (ADSs) in the United States

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jul 2019
Related companies:  Genmab A/S

Fulcrum Therapeutics Announces Pricing of Initial Public Offering

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jul 2019
Related companies:  Fulcrum Therapeutics

Acacia Pharma Founder Dr. Julian Gilbert steps down - Michael Bolinder, Chief Commercial Officer, becomes CEO in Planned Succession

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jul 2019
Related companies:  Acacia Pharma

Pixium Vision announced sustained success of its PRIMA System after 12-months in dry age-related macular degeneration patients

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jul 2019
Related companies:  Pixium Vision S.A.

ObsEva to Increase Issued Share Capital by Creating Additional Treasury Shares

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jul 2019
Related companies:  ObsEva SA

Orphazyme completes enrollment in phase 3 trial evaluating arimoclomol in Amyotrophic Lateral Sclerosis

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jul 2019
Related companies:  Orphazyme A/S

Novartis delivers strong sales, double digit core operating income growth and launches Zolgensma and Piqray in second quarter; sales and profit guidance increased

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jul 2019
Related companies:  Novan, Inc.

GenScript Biotech's Biologics R&D and production center is formally put into operation

NANJING, China, July 17, 2019 /PRNewswire/ -- GenScript Biotech Corp., one of the leading Biologics contract development and manufacturing organizations (CDMOs) in China, today announced that its Biologics research and development (R&D) and production center was formally put into operation... Read more ››

By: PR Newswire Association LLC. - 18 Jul 2019

Idalis Bailey, CEO of Renew Esthetics Medical Spa to Receive Prestigious Awards at the 2019 Aesthetic Everything® Aesthetic and Cosmetic Medicine Awards

ASTORIA, N.Y., July 17, 2019 /PRNewswire/ -- Renew Esthetics Medical Spa wins "Top Medical Spa East" and Idalis Bailey wins "Top Aesthetic Nurse" and "Top Aesthetician" in the 2019 Aesthetic Everything® Aesthetic and Cosmetic Medicine Awards.

Read more ››
By: PR Newswire Association LLC. - 18 Jul 2019

Forty Seven, Inc. Prices Underwritten Public Offering of 9,375,000 Shares of Common Stock

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jul 2019
Related companies:  Forty Seven Inc.

Janssen Korea Ltd. and Johnson & Johnson Innovation Announce Launch of Seoul Innovation QuickFire Challenge in Smart Healthcare in Collaboration with Seoul Metropolitan Government and Korea Health Industry Development Institute

SEOUL, South Korea, July 17, 2019 /PRNewswire/ -- Janssen Korea Ltd. and Johnson & Johnson Innovation LLC today announced the launch of the Seoul Innovation QuickFire Challenge in Smart Healthcare in collaboration with the Seoul Metropolitan Government and the Korea Health Industry... Read more ››

By: PR Newswire Association LLC. - 18 Jul 2019

Fossil Remedies announces New PCD Pharma Franchise Business Program across India

AHMEDABAD, India, July 17, 2019 /PRNewswire/ -- Fossil Remedies, which is a manufacturer and marketer of pharmaceutical products in the healthcare industry, announced the implementation of their new PCD Pharma Franchise Program on Monday. The primary goal of this announcement is to launch an... Read more ››

By: PR Newswire Association LLC. - 18 Jul 2019
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20 21  22  23  24  25 »

Explore our database of over 50,000 companies